Lp-PLA2 gene polymorphisms, plasma levels of Lp-PLA2, and risk of coronary heart disease: Results from a large case-control study

被引：0
|
作者：
Khuseyinova, N
Rothenbacher, D
Hoffmann, MM
Brenner, H
Koenig, W
机构：
[1] Univ Ulm, Med Ctr, Ulm, Germany
[2] Univ Heidelberg, German Ctr Res Aging, Heidelberg, Germany
[3] Univ Freiburg, Freiburg, Germany
来源：
CIRCULATION | 2006年 / 113卷 / 08期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
P58
引用
收藏
页码：E322 / E322
页数：1
相关论文
共 50 条
  • [21] Metalloproteases 2 and 9, Lp-PLA2 and Lipoprotein Profile in Coronary Patients
    Luz Muzzio, Maria
    Miksztowlcz, Veronica
    Brites, Fernando
    Aguilar, Daniel
    Martin Repetto, Esteban
    Wikinski, Regina
    Tavella, Marcelo
    Schreier, Laura
    Alicia Berg, Gabriela
    ARCHIVES OF MEDICAL RESEARCH, 2009, 40 (01) : 48 - 53
  • [22] The relation between Lp-PLA2 levels with periodic limb movements
    Taha Tahir Bekci
    Mehmet Kayrak
    Aysel Kiyici
    Hatem Ari
    Turgut Teke
    Emin Maden
    Hakan Akilli
    Sleep and Breathing, 2012, 16 : 117 - 122
  • [23] Lp-PLA2: Inflammatory Biomarker of Vascular Risk in Multiple Sclerosis
    Sternberg, Zohara
    Drake, Alison
    Sternberg, Daniel S.
    Benedict, Ralph H. B.
    Li, Fan
    Hojnacki, David
    Weinstock-Guttmann, Bianca
    Munschauer, Frederick E.
    JOURNAL OF CLINICAL IMMUNOLOGY, 2012, 32 (03) : 497 - 504
  • [24] Lp-PLA2: Inflammatory Biomarker of Vascular Risk in Multiple Sclerosis
    Zohara Sternberg
    Alison Drake
    Daniel S. Sternberg
    Ralph H. B. Benedict
    Fan Li
    David Hojnacki
    Bianca Weinstock-Guttmann
    Frederick E. Munschauer
    Journal of Clinical Immunology, 2012, 32 : 497 - 504
  • [25] The role of Lp-PLA2 and biochemistry parameters as potential biomarkers of coronary artery disease in Asian South-Indians: a case-control study
    Sairam, Sai Giridhar
    Sola, Srikanth
    Barooah, Asha
    Javvaji, Sai Kiran
    Jaipuria, Jiten
    Venkateshan, Vijayalakshmi
    Chelli, Janardhana
    Sanjeevi, Carani Balaraman
    CARDIOVASCULAR DIAGNOSIS AND THERAPY, 2017, 7 (06) : 589 - 597
  • [26] Impact of Plasma Lp-PLA2 Activity on the Progression of Aortic Stenosis The PROGRESSA Study
    Capoulade, Romain
    Mahmut, Ablajan
    Tastet, Lionel
    Arsenault, Marie
    Bedard, Elisabeth
    Dumesnil, Jean G.
    Despres, Jean-Pierre
    Larose, Eric
    Arsenault, Benoit J.
    Bosse, Yohan
    Mathieu, Patrick
    Pibarot, Philippe
    JACC-CARDIOVASCULAR IMAGING, 2015, 8 (01) : 26 - 33
  • [27] Genetic invalidation of Lp-PLA2 as a therapeutic target: Large-scale study of five functional Lp-PLA2-lowering alleles
    Gregson, John M.
    Freitag, Daniel F.
    Surendran, Praveen
    Stitziel, Nathan O.
    Chowdhury, Rajiv
    Burgess, Stephen
    Kaptoge, Stephen
    Gao, Pei
    Staley, James R.
    Willeit, Peter
    Nielsen, Sune F.
    Caslake, Muriel
    Trompet, Stella
    Polfus, Linda M.
    Kuulasmaa, Kari
    Kontto, Jukka
    Perola, Markus
    Blankenberg, Stefan
    Veronesi, Giovanni
    Gianfagna, Francesco
    Mannisto, Satu
    Kimura, Akinori
    Lin, Honghuang
    Reilly, Dermot F.
    Gorski, Mathias
    Mijatovic, Vladan
    Munroe, Patricia B.
    Ehret, Georg B.
    Thompson, Alex
    Uria-Nickelsen, Maria
    Malarstig, Anders
    Dehghan, Abbas
    Vogt, Thomas F.
    Sasaoka, Taishi
    Takeuchi, Fumihiko
    Kato, Norihiro
    Yamada, Yoshiji
    Kee, Frank
    Mueller-Nurasyid, Martina
    Ferrieres, Jean
    Arveiler, Dominique
    Amouyel, Philippe
    Salomaa, Veikko
    Boerwinkle, Eric
    Thompson, Simon G.
    Ford, Ian
    Jukema, J. Wouter
    Sattar, Naveed
    Packard, Chris J.
    Majumder, Abdulla al Shafi
    EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY, 2017, 24 (05) : 492 - 504
  • [28] RELATIONSHIP BETWEEN SERUM LP-PLA2, MIP-1A AND MIF LEVELS AND PROGNOSIS IN PATIENTS WITH CORONARY HEART DISEASE
    Yang Zicong
    Lin Yingzhong
    Yuan Jun
    Shi Ying
    Liu Yu
    Lu Zhengde
    Xue Yan
    Liu Ling
    ACTA MEDICA MEDITERRANEA, 2019, 35 (01): : 285 - 289
  • [29] Association of Lp-PLA2 mass and heart failure in a cohort of Nantong population
    Sheng, Guohua
    Shen, Yi
    Wu, Xiang
    Zhu, Jianhua
    Qin, Xiaotong
    Gui, Le
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2017, 10 (10): : 14605 - 14613
  • [30] Therapeutic options to reduce Lp-PLA2 levels and the potential impact on vascular risk reduction
    Ishida K.
    Cucchiara B.
    Current Treatment Options in Cardiovascular Medicine, 2013, 15 (3) : 313 - 321
12345